IRCT20160625028622N2
Recruiting
Phase 2
The effectiveness of dietary supplements containing antioxidant compounds on survival rate of patients with COVID-19
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Qazvin University of Medical Sciences
- Enrollment
- 50
- Status
- Recruiting
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •A positive PCR test for a new coronavirus
- •Having an involvement in a CT scan of the lungs and a definitive diagnosis by the treating physician that the person is infected
- •Therefore, people whose confirmed results of this virus are confirmed and who have 2 or more of the following symptoms will be studied in the following study: Including: Patients with pulmonary involvement of 50% and above (severe cases) (sometimes closed At the discretion of the physician and the patient's condition, lower lung involvement is also a criterion for hospitalization (moderate cases), 90 \<O2 saturation \<94 (moderate to severe cases) and o2 saturation \<90 (severe cases), sub\-cough symptoms (visual assessment criteria) Sore throat (patient report), headache (patient report), nasal congestion (patient report), fever (temperature above 37\.3\), body aches and pains (patient report), fatigue (patient report)
Exclusion Criteria
- •Patients suspected of having a bacterial respiratory infection at the beginning of the study
- •Patients with serious chronic diseases.
- •Pregnant women
- •Patients with HIV
- •Patients with cancer
- •Patients with vascular disease
- •Patient with endocrine disease
- •Patients who become infected during studying
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Safety and efficacy of a dietary supplement containing bovine alpha S1-casein tryptic hydrolysate and Hemerocallis fulva on sleep disorders among Japanese adultssleep disordersJPRN-UMIN000013349DHC Corporation10
Completed
Not Applicable
Safety and efficacy of a dietary supplement containing Irvingia gabonensis extract.obesityJPRN-UMIN000015534DHC Corporation20
Completed
Not Applicable
The efficacy evaluation of the dietary supplement on movement of the knee joint and walking functioHealthy adultJPRN-UMIN000043053EP Mediate Co., Ltd.54
Completed
Not Applicable
The efficacy evaluation of the dietary supplement on discomfort, bending and stretching of the low backoneJPRN-UMIN000037671TTC Co., Ltd54
Completed
Not Applicable
The efficacy evaluation of the dietary supplement (composite material) on the low back pain and physicaloneJPRN-UMIN000036216TTC Co., Ltd70